UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2023 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 0-16211 DENTSPLY SIRONA Inc. (Exact name of registrant as specified in its charter) Delaware 39-1434669 (State or other jurisdiction of (I.R.S. Emp ...

DENTSPLY SIRONA, Inc. (NASDAQ:XRAY) Q2 2023 Earnings Conference Call August 3, 2023 8:30 AM ET Company Participants Andrea Daley - Vice President, Investor Relations Simon Campion - President and Chief Executive Officer Glenn Coleman - Executive Vice President, Chief Financial Officer Andreas Frank - Executive Vice President, Chief Business Officer Conference Call Participants Elizabeth Anderson - Evercore ISI Michael Cherny - Bank of America Jeff Johnson - Baird Kevin Caliendo - UBS Jonathan Block - Stifel ...

Second Quarter 2023 Earnings Conference Call August 3, 2023 Forward-Looking Statements and Associated Risks This presentation contains statements that do not directly and exclusively relate to historical facts which constitute forward-looking statements, including, statements and projections concerning, among other things, the expected timing, benefits and costs associated with the Company's restructuring plan described in this presentation. The Company's forward-looking statements represent current expecta ...

DENTSPLY SIRONA, Inc. (NASDAQ:XRAY) Q1 2023 Earnings Conference Call May 3, 2023 8:30 AM ET Company Participants Andrea Daley - VP, IR Simon Campion - CEO, President & Director Glenn Coleman - EVP & CFO Andreas Frank - EVP & Chief Business Officer Conference Call Participants Elizabeth Anderson - Evercore ISI Jeffrey Johnson - Robert W. Baird & Co. Erin Wright - Morgan Stanley Daniel Clark - Bank of America Merrill Lynch Brandon Vazquez - William Blair & Company Jonathan Block - Stifel, Nicolaus & Company ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2023 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 0-16211 DENTSPLY SIRONA Inc. (Exact name of registrant as specified in its charter) Delaware 39-1434669 (State or other jurisdiction of (I.R.S. Em ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K x ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2022 OR o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission File Number 0-16211 DENTSPLY SIRONA Inc. (Exact name of registrant as specified in its charter) Delaware 39-1434669 (State or other jurisdiction of incorporation or organization) (I.R.S. Employe ...

DENTSPLY SIRONA Inc. (NASDAQ:XRAY) Q4 2022 Earnings Conference Call February 28, 2023 8:30 AM ET Company Participants Andrea Daley - Vice President-Investor Relations Simon Campion - Chief Executive Officer Glenn Coleman - Chief Financial Officer Conference Call Participants Dylan Finley - UBS Elizabeth Anderson - Evercore ISI Brandon Couillard - Jefferies Nathan Rich - Goldman Sachs Erin Wright - Morgan Stanley Jeff Johnson - RW Baird Michael Cherny - Bank of America Justin Lin - William Blair Rachel Vatns ...

Fourth Quarter 2022 Earnings and 2023 Outlook February 28, 2023 2 Forward-Looking Statements and Associated Risks This Presentation contains statements that do not directly and exclusively relate to historical facts which constitute forward-looking statements, including, statements and projections concerning, among other things, the expected timing, benefits and costs associated with the Company's restructuring plan described in this Presentation. The Company's forward-looking statements represent current e ...

DENTSPLY SIRONA Inc. (NASDAQ:XRAY) Q3 2022 Earnings Conference Call November 14, 2022 8:30 AM ET Company Participants Andrea Daley - VP, IR Simon Campion - Chief Executive Officer Glenn Coleman - Chief Financial Officer Conference Call Participants Kevin Caliendo - UBS Elizabeth Anderson - Evercore Nathan Rich - Goldman Sachs Erin Wright - Morgan Stanley Brandon Couillard - Jefferies Jeffrey Johnson - Baird Daniel Clark - Bank of America Jonathan Block - Stifel Michael Petusky - Barrington Research Jason ...

4 " " Third Quarter 2022 Earnings Conference Call November 14, 2022 2 Forward-Looking Statements and Associated Risks All statements in this presentation that do not directly and exclusively relate to historical facts constitute "forward-looking statements." These statements represent current expectations and beliefs, and no assurance can be given that the results described in such statements will be achieved. Such statements are subject to numerous assumptions, risks, uncertainties and other factors that c ...